Pacira BioSciences, Inc. (PCRX) Insider Trading
Over the last 3 months, PCRX insiders made 0 open-market buys and 5 sales, a net sale of -$929K (SEC Form 4). Over the last 6 months, 185 institutions increased and 180 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$929.2K
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
Jun
Context3-month price +12.3%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 12, 2026 | Hirawat Samitdirector | Grant | 10,891 | $23.42 |
| Jun 12, 2026 | Brege Lauradirector | Grant | 6,405 | — |
| Jun 12, 2026 | Froimson Markdirector | Grant | 10,891 | $23.42 |
| Jun 12, 2026 | Froimson Markdirector | Grant | 6,405 | — |
| Jun 12, 2026 | Brege Lauradirector | Grant | 10,891 | $23.42 |
| Jun 12, 2026 | BIGAL MARCELOdirector | Grant | 6,405 | — |
| Jun 12, 2026 | YANG MICHAEL J.director | Grant | 6,405 | — |
| Jun 12, 2026 | YANG MICHAEL J.director | Grant | 10,891 | $23.42 |
| Jun 12, 2026 | RIKER LAURENofficer: Senior Vice President, Finance | Sell | 6,115 | $23.50 |
| Jun 12, 2026 | BIGAL MARCELOdirector | Grant | 10,891 | $23.42 |
| Jun 12, 2026 | Young Alethiadirector | Grant | 10,891 | $23.42 |
| Jun 12, 2026 | CHRISTIE CHRISTOPHERdirector | Grant | 6,405 | — |
| Jun 12, 2026 | Young Alethiadirector | Grant | 6,405 | — |
| Jun 12, 2026 | Hirawat Samitdirector | Grant | 6,405 | — |
| Jun 12, 2026 | CHRISTIE CHRISTOPHERdirector | Grant | 10,891 | $23.42 |
| Jun 12, 2026 | WIGGANS THOMAS Gdirector | Grant | 32,675 | $23.42 |
| Jun 5, 2026 | WILLIAMS KRISTENofficer: Chief Administrative Officer | Tax | 8,528 | $22.32 |
| Jun 5, 2026 | RIKER LAURENofficer: Senior Vice President, Finance | Tax | 3,187 | $22.32 |
| Jun 5, 2026 | WILLIAMS KRISTENofficer: Chief Administrative Officer | Sell | 10,259 | $22.27 |
| Jun 5, 2026 | SLONIN JONATHANofficer: Chief Medical Officer | Tax | 4,728 | $22.32 |
| Apr 24, 2026 | Cross Shawnofficer: Chief Financial Officer | Sell | 12,941 | $25.16 |
| Apr 24, 2026 | Cross Shawnofficer: Chief Financial Officer | Option | 12,941 | $16.45 |
| Apr 22, 2026 | Cross Shawnofficer: Chief Financial Officer | Sell | 7,714 | $25.14 |
| Apr 22, 2026 | Cross Shawnofficer: Chief Financial Officer | Option | 7,714 | $16.45 |
| Apr 22, 2026 | Cross Shawnofficer: Chief Financial Officer | Option | 2,845 | $16.45 |
| Apr 22, 2026 | Cross Shawnofficer: Chief Financial Officer | Option | 1,500 | $16.45 |
| Apr 22, 2026 | Cross Shawnofficer: Chief Financial Officer | Sell | 1,500 | $25.01 |
| Mar 19, 2026 | SLONIN JONATHANofficer: Chief Medical Officer | Sell | 3,261 | $22.82 |
| Mar 19, 2026 | Froimson Markdirector | Sell | 500 | $21.81 |
| Mar 19, 2026 | Kronenfeld Mark A.director | Grant | 6,163 | — |
Source: PCRX SEC Form 4 filings, latest Jun 12, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their PCRX positions over the last 6 months (SEC Form 13F).
Increased
185
New positions
70
Reduced
180
Sold out
66
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Reduced | 7.1M | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 6.7M | May 13, 2026 |
| VANGUARD GROUP INC | Reduced | 4.8M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3.6M | May 15, 2026 |
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC | Increased | 2.8M | Feb 17, 2026 |
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC | Unchanged | 2.8M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2.5M | May 8, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2.1M | May 7, 2026 |
| D. E. SHAW & CO., INC. | Increased | 2.0M | Feb 17, 2026 |
| D. E. SHAW & CO., INC. | Reduced | 2.0M | May 15, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 2.0M | Feb 12, 2026 |
| STATE STREET CORP | Increased | 1.9M | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 1.9M | Feb 12, 2026 |
| STATE STREET CORP | Reduced | 1.9M | Feb 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 1.8M | May 14, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.